Progression of vertebral fractures in metastatic melanoma and non-small cell lung cancer patients given immune checkpoint inhibitors
Concurrent steroid therapy in patients receiving immunotherapy exposes them to a high risk of fractures due to skeletal fragility. The use of bone resorption inhibitors should be considered in these patients to prevent these adverse events.
Authors
- Salvatore Grisanti (ORCID: https://orcid.org/0000-0001-6922-1934)
- Luca Carlofrancesco Ammoni
- Valeria Tovazzi
- Marco Ravanelli (ORCID: https://orcid.org/0000-0002-4841-2771)
- Francesca Salvotti
- Greta Schivardi
- Alfredo Berruti (ORCID: https://orcid.org/0000-0002-2952-9560)
- Davide Farina (ORCID: https://orcid.org/0000-0003-4075-0001)
- Alice Baggi
- Manuel Zamparini (ORCID: https://orcid.org/0000-0002-4202-6298)
- Andrea Alberti (ORCID: https://orcid.org/0000-0002-1619-1986)
- Marco Meazza Prina
- Margherita Parolise
- L. Guarneri
Institutions
- University of Brescia (IT)
Publication Details
- Journal
- Journal of bone oncology
- Published
- 2024-10-11
- DOI
- https://doi.org/10.1016/j.jbo.2024.100642
- Citations
- 3
- Primary Topic
- Management of metastatic bone disease
- Type
- article
- Field-Weighted Citation Impact
- 1.72